SRP14 has a well-described role in protein targeting in the endoplasmic reticulum, has a high probability of being loss-of-function intolerant (pLi), and is essential for leukaemia and lymphoid malignancy cell survival, as shown using CRISPR knockout models17. The gene discussed is SERPINF2; the disease is leukemia.